ImportRefusal LogoImportRefusal

Apex Well (Asia) Limited

⚠️ High Risk

FEI: 3003955782 • Kowloon • HONG KONG

FEI

FEI Number

3003955782

📍

Location

Kowloon

🇭🇰

Country

HONG KONG
🏢

Address

Flat A, 1/F, China Paint Building,, , Kowloon, , Hong Kong

High Risk

FDA Import Risk Assessment

50.8
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

11
Total Refusals
6
Unique Violations
8/3/2005
Latest Refusal
5/12/2004
Earliest Refusal

Score Breakdown

Violation Severity
74.7×40%
Refusal Volume
40.0×30%
Recency
0.0×20%
Frequency
89.6×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

8310×

NO PROCESS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the manufacturer's failure to file a scheduled process demonstrates that the product is not being manufactured under the mandatory provisions of 21 CFR Part 108 and therefore appears to have been manufactured, processed, or packed, under insanitary conditions whereby it may have been rendered injurious to health.

623×

NEEDS FCE

It appears the manufacturer is not registered as a low acid canned food or acidified food manufacturer pursuant to 21 CFR 108.25(c)(1) or 108.35(c)(1).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

3351×

LACKS N/C

The article is in package form and appears to not have a label containing an accurate statement of the quantity of the contents in terms of weight, measure or numerical count and no variations or exemptions have been prescribed by regs.

4831×

DRUG NAME

The article appears to be a drug and fails to bear the proprietary or established name and/or name and quantity of each active ingredient.

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
8/3/2005
62VBL99ANTI-VIRAL N.E.C.
118NOT LISTED
335LACKS N/C
483DRUG NAME
75UNAPPROVED
San Francisco District Office (SAN-DO)
6/28/2004
29AEE99NONCARBONATED SOFT DRINK, N.E.C.
83NO PROCESS
Los Angeles District Office (LOS-DO)
6/28/2004
29AEE99NONCARBONATED SOFT DRINK, N.E.C.
83NO PROCESS
Los Angeles District Office (LOS-DO)
6/28/2004
29ACE99NONCARBONATED SOFT DRINK, N.E.C.
83NO PROCESS
Los Angeles District Office (LOS-DO)
6/28/2004
29ACE99NONCARBONATED SOFT DRINK, N.E.C.
83NO PROCESS
Los Angeles District Office (LOS-DO)
6/28/2004
29ACE99NONCARBONATED SOFT DRINK, N.E.C.
83NO PROCESS
Los Angeles District Office (LOS-DO)
5/19/2004
29AEE99NONCARBONATED SOFT DRINK, N.E.C.
83NO PROCESS
Los Angeles District Office (LOS-DO)
5/19/2004
29ACE99NONCARBONATED SOFT DRINK, N.E.C.
83NO PROCESS
Los Angeles District Office (LOS-DO)
5/12/2004
29ACT99NONCARBONATED SOFT DRINK, N.E.C.
62NEEDS FCE
83NO PROCESS
San Francisco District Office (SAN-DO)
5/12/2004
29ACT99NONCARBONATED SOFT DRINK, N.E.C.
62NEEDS FCE
83NO PROCESS
San Francisco District Office (SAN-DO)
5/12/2004
29ACT99NONCARBONATED SOFT DRINK, N.E.C.
62NEEDS FCE
83NO PROCESS
San Francisco District Office (SAN-DO)

Frequently Asked Questions

What is Apex Well (Asia) Limited's FDA import refusal history?

Apex Well (Asia) Limited (FEI: 3003955782) has 11 FDA import refusal record(s) in our database, spanning from 5/12/2004 to 8/3/2005.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Apex Well (Asia) Limited's FEI number is 3003955782.

What types of violations has Apex Well (Asia) Limited received?

Apex Well (Asia) Limited has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Apex Well (Asia) Limited come from?

All FDA import refusal data for Apex Well (Asia) Limited is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.